Semaglutide treatment for PRevention Of Toxicity in high-dosE Chemotherapy with autologous haematopoietic stem-cell Transplantation (PROTECT): study protocol for a randomised, double-blind, placebo-controlled, investigator-initiated study

Authors

Dorte Tholstrup
Anne Ortved Gang (ORCID: https://orcid.org/0000-0003-0160-1257)
Brian Kornblit
Klaus Müller (ORCID: https://orcid.org/0000-0002-5278-1983)
Hannelouise Kissow (ORCID: https://orcid.org/0000-0001-9351-8885)
Maria Ebbesen Sørum (ORCID: https://orcid.org/0000-0002-3907-7916)
Filip K. Knop (ORCID: https://orcid.org/0000-0002-2495-5034)
Sif Gudbrandsdottir (ORCID: https://orcid.org/0000-0002-0662-3335)

Institutions

University of Copenhagen (DK)
Copenhagen University Hospital (DK)
Gentofte Hospital (DK)
Zealand University Hospital (DK)

Publication Details

Journal: BMJ Open
Published: 2024-10-01
DOI: https://doi.org/10.1136/bmjopen-2024-089862
Citations: 4
Primary Topic: Neuroendocrine Tumor Research Advances
Type: article
Field-Weighted Citation Impact: 1.55

Funders

Novo Nordisk
Danmarks Frie Forskningsfond

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Semaglutide treatment for PRevention Of Toxicity in high-dosE Chemotherapy with autologous haematopoietic stem-cell Transplantation (PROTECT): study protocol for a randomised, double-blind, placebo-controlled, investigator-initiated study

Dorte Tholstrup, Anne Ortved Gang, Brian Kornblit, Klaus Müller et al.

Oct 1, 2024

4 citations

BMJ Open

Neuroendocrine Tumor Research Advances

1.55

article

Semaglutide treatment for PRevention Of Toxicity in high-dosE Chemotherapy with autologous haematopoietic stem-cell Transplantation (PROTECT): study protocol for a randomised, double-blind, placebo-controlled, investigator-initiated study

Dorte Tholstrup, Anne Ortved Gang, Brian Kornblit, Klaus Müller, Hannelouise Kissow, Maria Ebbesen Sørum, Filip K. Knop, Sif Gudbrandsdottir

October 1, 2024article en

4 citations

Abstract

No abstract available for this paper.

BMJ OpenVol. 14(10)

University of Copenhagen (DK), Copenhagen University Hospital (DK), Gentofte Hospital (DK), Zealand University Hospital (DK)

Novo Nordisk, Danmarks Frie Forskningsfond

Good health and well-being

Openalex Percentile: Top 16%

Neuroendocrine Tumor Research Advances

1.55

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.